Masuu Global Solutions, founded in 2018, is a burgeoning player in the Biopharma and Pharmaceutical sectors, headquartered in the United States. The company's slogan, "Global Pharma Regulatory, Quality Services & Software Company," aptly describes its wide range of offerings and global reach.
With a workforce of over 280 Subject Matter Experts (SMEs), and a leadership team that includes former personnel from major health authorities such as the USFDA, EMA, and MHRA, Masuu Global has positioned itself as a trusted partner to more than 450 international clients. This roster includes industry giants like AbbVie, Allergan, and Cipla.
The company's services span crucial areas such as Quality/cGMP and GxP Audits, CMC Dossier Writing, and Regulatory and Medical Writing. Their proprietary Pharma Software solutions further underscore their technological capabilities.
Notably, Masuu Global Solutions has not disclosed any recent investments or investor participation, which may present opportunities for new investment engagements.